To clarify the treatment of certain DNA Specimen Provenance Assay tests as reasonable and necessary for the diagnosis or treatment of illness for coverage under the Medicare program.
The bill’s titles are written by its sponsor.
Jul 13, 2016
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on July 13, 2016, in a previous session of Congress, but was not enacted.
Representative for Indiana's 8th congressional district
Read Text »
Last Updated: Jul 13, 2016
Length: 3 pages
Reintroduced Bill — Introduced
This activity took place on a related bill, H.R. 2557.
H.R. 5763 (114th) was a bill in the United States Congress.
How to cite this information.
Civic Impulse. (2017). H.R. 5763 — 114th Congress: Prostate Cancer Misdiagnosis Elimination Act of 2016. Retrieved from https://www.govtrack.us/congress/bills/114/hr5763
“H.R. 5763 — 114th Congress: Prostate Cancer Misdiagnosis Elimination Act of 2016.” www.GovTrack.us. 2016. July 23, 2017 <https://www.govtrack.us/congress/bills/114/hr5763>
|title=H.R. 5763 (114th)
|accessdate=July 23, 2017
|author=114th Congress (2016)
|date=July 13, 2016
|quote=Prostate Cancer Misdiagnosis Elimination Act of 2016